Body mass index as a predictive factor for efficacy of adjuvant taxane-based chemotherapy in early-stage breast cancer patients: A pooled analysis from adjuvant GEICAM Spanish Breast Cancer Group and TRIO Translational Research in Oncology Group studies. - García-Saenz JA; Spera G; Pollán M; Bermejo B; Ruiz-Borrego M; Chan A; Martín M; Guerrero-Zotano Á; Calvo L; Rodríguez-Lescure Á; Marín M; Chap L; et al. (International journal of cancer, 2025)